Low Back Pain (Central Nervous System) Pipeline Review, H2 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Low
Back Pain – Pipeline Review, H2 2018”
drug pipelines has been
added to ResearchAndMarkets.com’s offering.

Low Back Pain (Central Nervous System), complete with analysis by stage
of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.

The Low Back Pain (Central Nervous System) pipeline guide also reviews
of key players involved in therapeutic development for Low Back Pain and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities /Institutes,
the molecules developed by Companies in Pre-Registration, Phase III,
Phase II, Phase I, Preclinical and Discovery stages are 1, 6, 12, 3, 4
and 1 respectively.

Low Back Pain (Central Nervous System) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Low Back Pain – Overview
  3. Low Back Pain – Therapeutics Development
  4. Low Back Pain – Therapeutics Assessment
  5. Low Back Pain – Companies Involved in Therapeutics Development
  6. Low Back Pain – Drug Profiles
  7. Low Back Pain – Dormant Projects
  8. Low Back Pain – Discontinued Products
  9. Low Back Pain – Product Development Milestones
  10. Appendix

Companies Mentioned

  • Ache Laboratorios Farmaceuticos SA
  • Adynxx Inc
  • AnGes Inc
  • Array BioPharma Inc
  • Axsome Therapeutics Inc
  • Camurus AB
  • Daewon Pharm Co Ltd
  • Egalet Corp
  • Frontier Biotechnologies Inc
  • Gador SA
  • Hisamitsu Pharmaceutical Co Inc
  • Immune Pharmaceuticals Inc
  • Inspyr Therapeutics Inc
  • MD Biosciences GmbH
  • Mesoblast Ltd
  • Nektar Therapeutics
  • Pacira Pharmaceuticals Inc
  • Pfizer Inc
  • Regeneron Pharmaceuticals Inc
  • Stayble Therapeutics AB
  • Therapix Biosciences Ltd
  • WEX Pharmaceuticals Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/p4df2c/low_back_pain?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Analgesics,
Musculoskeletal
Disorders Drugs

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.